The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or inhalation. A nasal COVID-19 vaccine, developed using technology from Washington ...
Equity markets performed well in January, as they often do, but as the dust settles on that early-year run, the strategy for long-term investors remains the same: Invest in companies that can perform ...
COVID-19 revealed weaknesses in our pandemic response plans and sowed distrust in science. Can we get it back?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback